TELMODOR M 40/25 10S

About

TELMODOR M 40/25 is a combination medication featuring Telmisartan, an angiotensin II receptor blocker (ARB), and Metoprolol, a beta-1 selective adrenergic blocking agent. This formulation is specifically designed for the effective management of essential hypertension, particularly in patients whose blood pressure is not adequately controlled by monotherapy with either component. Telmisartan exerts its antihypertensive effect by selectively blocking the binding of angiotensin II to the AT1 receptor, thereby preventing vasoconstriction and aldosterone secretion, which leads to vasodilation and a reduction in blood pressure. Concurrently, Metoprolol works by reducing heart rate, myocardial contractility, and cardiac output, further contributing to a significant decrease in systemic blood pressure. The synergistic action of these two agents addresses multiple physiological pathways involved in blood pressure regulation, providing comprehensive and sustained control, and improving overall cardiovascular outcomes for patients requiring dual therapy.

Uses

• Treatment of essential hypertension.
• Management of hypertension in patients requiring multiple agents.
• Reduction of cardiovascular risk in high-risk individuals.
• Improvement of blood pressure control in resistant hypertension.

Directions For Use

Take orally once daily, with or without food, as directed by your physician. Do not crush or chew the tablet.

Benefits

• Potent blood pressure reduction.
• Dual mechanism of action.
• Reduces heart rate and cardiac workload.
• Once-daily dosing for adherence.
• Suitable for patients with co-existing conditions like angina.
• Offers sustained antihypertensive effect.

Side Effects

• Dizziness
• Bradycardia
• Fatigue
• Headache
• Nausea
• Diarrhea
• Cold extremities
• Hypotension
• Bronchospasm (rare)
• Sleep disturbances
• Hyperkalemia
• Masking of hypoglycemia symptoms

Safety Measures

• Alcohol - May enhance the hypotensive effect and increase dizziness. Avoid or limit alcohol consumption.
• Pregnancy - Contraindicated in the second and third trimesters due to fetal harm risk from telmisartan. Metoprolol use requires careful consideration.
• Breastfeeding - Not recommended as both components may pass into breast milk. Consult a physician.
• Liver - Use with caution in hepatic impairment; dosage adjustments may be necessary.
• Kidney - Use with caution in renal impairment; monitor kidney function regularly.
• Lung - Use with caution in patients with asthma or COPD due to metoprolol's beta-blocking effects, even if cardioselective.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.